Table 5.
Other blood biomarkers.
| Biomarker | ALS | Controls | Finding | Reference |
|---|---|---|---|---|
| C9orf72 | 2 | 2H | Mononuclear cell binding of mutant c9orf72 to tri-CH3 histone residues | [94] |
| EMMPRIN | 50 | 50H | High serum level Correlated with severity |
[95] |
| ICTP | 21 | 16ND | High serum level Correlated with duration |
[96] |
| Lead | 184 | 194H | High level Correlated with risk of ALS |
[97] |
| MMP-2 | 30 | 15H | Correlated with severity | [98] |
| MMP-9 | 14 | 20H 45ND | High serum level | [99] |
| PICP | 21 | 16ND | Low serum level | [96] |
| TDP-43 | 16 | 13H | Cytoplasmic lymphomonocyte location in ALS subtype | [100] |
| 219 | 100H | High plasma level | [101] | |
| Type IV collagen | 30 | 30H 14ND | Correlated with duration | [102] |
H: healthy; ND: neurological/neurodegenerative disease; EMMPRIN: extracellular matrix metalloproteinase inducer; ICTP: cross-linked telopeptide of type I collagen; MMP: matrix metalloproteinase; PICP: propeptide of type I procollagen; TDP-43: TAR DNA binding protein-43.